Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment with recombinant ADAMTS13, alleviates hypoxia/reoxygenation-induced pathologies in a mouse model of human sickle cell disease.
Rossato P, Glantschnig H, Canneva F, Schuster M, Coulibaly S, Schrenk G, Voelkel D, Dockal M, Plaimauer B, Rottensteiner H, Gritsch H, Federti E, Matte A, De Franceschi L, Scheiflinger F, Hoellriegl W. Rossato P, et al. Among authors: dockal m. J Thromb Haemost. 2023 Feb;21(2):269-275. doi: 10.1016/j.jtha.2022.10.016. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36700507 Free article.
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease.
Rossato P, Federti E, Matte A, Glantschnig H, Canneva F, Schuster M, Coulibaly S, Schrenk G, Voelkel D, Dockal M, Plaimauer B, Andolfo I, Iolascon A, Rottensteiner H, Gritsch H, Scheiflinger F, Hoellriegl W, Franceschi L. Rossato P, et al. Among authors: dockal m. Haematologica. 2022 Nov 1;107(11):2650-2660. doi: 10.3324/haematol.2021.280233. Haematologica. 2022. PMID: 35443560 Free PMC article.
Evaluation of Factor VIII Polysialylation: Identification of a Longer-Acting Experimental Therapy in Mice and Monkeys.
Glantschnig H, Bauer A, Benamara K, Dockal M, Ehrlich V, Gritsch H, Höbarth G, Horling FM, Kopic A, Leidenmühler P, Reipert BM, Rottensteiner H, Ruthsatz T, Schrenk G, Schuster M, Turecek PL, Weber A, Wolfsegger M, Scheiflinger F, Höllriegl W. Glantschnig H, et al. Among authors: dockal m. J Pharmacol Exp Ther. 2019 Oct;371(1):95-105. doi: 10.1124/jpet.119.260067. Epub 2019 Jul 31. J Pharmacol Exp Ther. 2019. PMID: 31366602
Factor IX mutants with enhanced catalytic activity.
Hartmann R, Dockal M, Kammlander W, Panholzer E, Nicolaes GA, Fiedler C, Rosing J, Scheiflinger F. Hartmann R, et al. Among authors: dockal m. J Thromb Haemost. 2009 Oct;7(10):1656-62. doi: 10.1111/j.1538-7836.2009.03560.x. Epub 2009 Jul 28. J Thromb Haemost. 2009. PMID: 19656280 Free article.
Systemic antithrombotic effects of ADAMTS13.
Chauhan AK, Motto DG, Lamb CB, Bergmeier W, Dockal M, Plaimauer B, Scheiflinger F, Ginsburg D, Wagner DD. Chauhan AK, et al. Among authors: dockal m. J Exp Med. 2006 Mar 20;203(3):767-76. doi: 10.1084/jem.20051732. Epub 2006 Mar 13. J Exp Med. 2006. PMID: 16533881 Free PMC article.
43 results